Erratum
28 May 2009
Reply:
Martin‐Walter Welker, Stefan Zeuzem – 28 May 2009
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns
Chia‐Yen Dai, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Yen Hsieh, Ming‐Lung Yu – 28 May 2009
Overexpression of insulin receptor substrate‐1 and hepatitis Bx genes causes premalignant alterations in the liver
Lisa Longato, Suzanne de la Monte, Noriyoshi Kuzushita, Masayoshi Horimoto, Arlin B. Rogers, Betty L. Slagle, Jack R. Wands – 28 May 2009 – Activation of the insulin (IN)/insulin receptor substrate‐1 (IRS‐1)/mitogen‐associated protein kinase (MAPK) and the Wnt/β‐catenin signaling cascades occurs frequently in hepatocellular carcinoma (HCC) associated with persistent viral infection.
Inhibition of c‐Jun NH2‐terminal kinase switches Smad3 signaling from oncogenesis to tumor‐ suppression in rat hepatocellular carcinoma
Hiromitsu Nagata, Etsuro Hatano, Masaharu Tada, Miki Murata, Koji Kitamura, Hiroyuki Asechi, Masato Narita, Atsuko Yanagida, Nobuyuki Tamaki, Shintaro Yagi, Iwao Ikai, Koichi Matsuzaki, Shinji Uemoto – 28 May 2009 – Transforming growth factor beta (TGF‐β) signaling involves both tumor‐suppression and oncogenesis. TGF‐β activates the TGF‐β type I receptor (TβRI) and c‐Jun N‐terminal kinase (JNK), which differentially phosphorylate the mediator Smad3 to become COOH‐terminally phosphorylated Smad3 (pSmad3C) and linker‐phosphorylated Smad3 (pSmad3L).
Phenotypic differences between two Gnmt−/− mouse models for hepatocellular carcinoma
- Read more about Phenotypic differences between two Gnmt−/− mouse models for hepatocellular carcinoma
Yi‐Ming Arthur Chen, Yi‐Jen Liao, Shih‐Ping Liu, Ting‐Fen Tsai – 28 May 2009
Impact factor: Misused and overhyped?
Patrick S. Kamath, Gregory Bologna – 28 May 2009
The utilization of liver transplantation in the management of acute liver failure: Comparison between acetaminophen and non‐acetaminophen etiologies
Kenneth J. Simpson, Caroline M. Bates, Neil C. Henderson, Stephen J. Wigmore, O. James Garden, Alistair Lee, Antony Pollok, George Masterton, Peter C. Hayes – 28 May 2009 – Liver transplantation (LT) may be life‐saving in severe acute liver failure (ALF). The aim of this study was to compare the utilization of LT in acetaminophen and non‐acetaminophen ALF. Between 1992 and 2006, 469 patients with ALF were admitted, and 104 underwent LT.
Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation
Aya Miyagawa‐Hayashino, Hiroto Egawa, Tohru Yorifuji, Makoto Hasegawa, Hironori Haga, Tatsuaki Tsuruyama, Mei‐Chin Wen, Ryo Sumazaki, Toshiaki Manabe, Shinji Uemoto – 28 May 2009 – We studied histological features and long‐term outcomes in patients with progressive familial intrahepatic cholestasis type 1 (PFIC1) after liver transplantation (LT). Histological findings were correlated with the post‐LT course and treatment in 11 recipients with PFIC1. Ages at LT varied from 1 to 18 years (median, 4 years).